To establish foundational biomanufacturing infrastructure that resolves the structural bottleneck limiting therapeutic advancement.

This work enables scalable, clinical-grade human tissue production and accelerates therapeutic translation by reducing the cost and complexity of preclinical development for academic researchers advancing engineered tissue technologies, clinicians developing restorative therapies, and biopharmaceutical partners seeking human-relevant testing platforms.

We are equally committed to advancing the broader public interest by anchoring high-skill employment, workforce development, and sustained economic growth in Pennsylvania.